HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Google Scholar Articles by Chang, A B Articles by Bilton, D PubMed PubMed Citation Articles by Chang, A B Articles by Bilton, D

Exacerbations in cystic fibrosis: 4 · Non-cystic fibrosis bronchiectasis

¹ Department of Respiratory Medicine, Royal Children’s Hospital and Child Health Division, Menzies School of Health Research, Charles Darwin University, Brisbane, Australia
² Lung Defence Unit, Papworth Hospital NHS Trust, Cambridge, UK

Correspondence to:
Dr A B Chang, Department of Respiratory Medicine, Royal Children’s Hospital, Herston Road, Brisbane, Queensland 4029, Australia; annechang{at}ausdoctors.net

Bronchiectasis unrelated to cystic fibrosis (CF) is increasingly recognised as an important and major primary respiratory disease in developing countries. In affluent countries, bronchiectasis is also increasingly recognised in subsections of communities (such as indigenous peoples) as well as a co-existent disease/co-morbidity and disease modifier in respiratory diseases such as chronic obstructive pulmonary disease. The epidemiology, pathogenesis, prevention and management of exacerbations of non-CF bronchiectasis are reviewed. There are few data on all aspects of exacerbations in bronchiectasis. Some of the management issues are common to non-CF and CF bronchiectasis, but it would be unwise to extrapolate from CF studies to non-CF bronchiectasis. In some situations this may be harmful.